Healthcare Trust of America (HTA) 10-Q 28 Oct 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Oct. 26, 2015
Entity Information [Line Items]
Entity Registrant Name	HEALTHCARE TRUST OF AMERICA, INC.
Entity Central Index Key	1,360,604
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		127,037,807
Healthcare Trust of America Holdings, LP (HTALP)
Entity Information [Line Items]
Entity Registrant Name	Healthcare Trust of America Holdings, LP
Entity Central Index Key	1,495,491
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Real estate investments:
Land	$ 298,515	$ 287,755
Building and improvements	2,871,512	2,665,777
Lease intangibles	430,678	419,288
Real estate investments, gross	3,600,705	3,372,820
Accumulated depreciation and amortization	(641,619)	(549,976)
Real estate investments, net ($0 and $80,419 from consolidated VIEs)	2,959,086	2,822,844
Cash and cash equivalents	11,146	10,413
Restricted cash and escrow deposits	17,714	20,799
Receivables and other assets, net	148,447	144,106
Other intangibles, net	43,193	43,488
Total assets	3,179,586	3,041,650
Liabilities:
Debt	1,575,965	1,412,461
Accounts payable and accrued liabilities	95,029	101,042
Derivative financial instruments - interest rate swaps	4,254	2,888
Security deposits, prepaid rent and other liabilities	39,261	32,687
Intangible liabilities, net	26,970	12,425
Total liabilities	$ 1,741,479	$ 1,561,503
Commitments and contingencies
Redeemable noncontrolling interests	$ 3,756	$ 3,726
Equity/Partners' Capital:
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding	0	0
Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 127,037,807 and 125,087,268 shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively	1,270	1,251
Additional paid-in capital	2,328,702	2,281,932
Cumulative dividends in excess of earnings	(923,556)	(836,044)
Total stockholders’ equity	1,406,416	1,447,139
Noncontrolling interests	27,935	29,282
Total equity	1,434,351	1,476,421
Total liabilities and equity/partners' capital	3,179,586	3,041,650
Healthcare Trust of America Holdings, LP (HTALP)
Real estate investments:
Land	298,515	287,755
Building and improvements	2,871,512	2,665,777
Lease intangibles	430,678	419,288
Real estate investments, gross	3,600,705	3,372,820
Accumulated depreciation and amortization	(641,619)	(549,976)
Real estate investments, net ($0 and $80,419 from consolidated VIEs)	2,959,086	2,822,844
Cash and cash equivalents	11,146	10,413
Restricted cash and escrow deposits	17,714	20,799
Receivables and other assets, net	148,447	144,106
Other intangibles, net	43,193	43,488
Total assets	3,179,586	3,041,650
Liabilities:
Debt	1,575,965	1,412,461
Accounts payable and accrued liabilities	95,029	101,042
Derivative financial instruments - interest rate swaps	4,254	2,888
Security deposits, prepaid rent and other liabilities	39,261	32,687
Intangible liabilities, net	26,970	12,425
Total liabilities	$ 1,741,479	$ 1,561,503
Commitments and contingencies
Redeemable noncontrolling interests	$ 3,756	$ 3,726
Equity/Partners' Capital:
Limited partners’ capital, 1,929,942 and 2,154,942 units issued and outstanding as of September 30, 2015 and December 31, 2014, respectively	27,665	29,012
General partners’ capital, 127,037,807 and 125,087,268 units issued and outstanding as of September 30, 2015 and December 31, 2014, respectively	1,406,686	1,447,409
Total partners’ capital	1,434,351	1,476,421
Total liabilities and equity/partners' capital	$ 3,179,586	$ 3,041,650

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Equity:
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Common Stock
Equity:
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	127,037,807	125,087,268
Common stock, shares outstanding	127,037,807	125,087,268
Variable Interest Entity, Primary Beneficiary
Real estate investments, VIE	$ 0	$ 80,419
Healthcare Trust of America Holdings, LP (HTALP)
Partners’ Capital:
Limited partner's capital, units issued	1,929,942	2,154,942
Limited partner's capital, units outstanding	1,929,942	2,154,942
General partner's capital, units issued	127,037,807	125,087,268
General partner's capital, units outstanding	127,037,807	125,087,268
Healthcare Trust of America Holdings, LP (HTALP) | Variable Interest Entity, Primary Beneficiary
Real estate investments, VIE	$ 0	$ 80,419

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended			9 Months Ended
		Sep. 30, 2015	Sep. 30, 2014		Sep. 30, 2015	Sep. 30, 2014
Revenues:
Rental income		$ 103,875	$ 95,277		$ 301,570	$ 274,675
Interest and other operating income		67	257		203	1,834
Total revenues		103,942	95,534		301,773	276,509
Expenses:
Rental		32,921	28,526		92,855	85,179
General and administrative		6,430	5,935		19,229	18,137
Acquisition-related		907	2,802		3,365	8,647
Depreciation and amortization		40,518	35,802		115,179	104,346
Impairment		0	0		1,655	0
Total expenses		80,776	73,065		232,283	216,309
Income before other income (expense)		23,166	22,469		69,490	60,200
Interest expense:
Interest related to derivative financial instruments		(903)	(1,433)		(2,278)	(4,148)
(Loss) gain on change in fair value of derivative financial instruments, net		(2,383)	2,564		(3,079)	(857)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments		(3,286)	1,131		(5,357)	(5,005)
Interest related to debt		(13,536)	(14,119)		(41,499)	(37,802)
Gain on sales of real estate, net		152	11,766		152	11,766
(Loss) gain on extinguishment of debt, net		(14)	(5,028)		107	(4,663)
Other income		72	1		91	41
Net income		6,554	16,220		22,984	24,537
Net income attributable to noncontrolling interests	[1]	(91)	(188)		(425)	(358)
Net income attributable to common stockholders/unitholders		$ 6,463	$ 16,032		$ 22,559	$ 24,179
Earnings per common share/unit - basic:
Net income attributable to common stockholders/unitholders (usd per share)		$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Earnings per common share/unit - diluted:
Net income attributable to common stockholders/unitholders (usd per share)		$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Weighted average number of common shares/units outstanding:
Basic (in shares/units)		126,863	119,484	[2]	125,750	119,049	[2]
Diluted (in shares/units)		128,793	120,716	[2]	127,680	120,304	[2]
Dividends/Distributions declared per common share/unit (usd per share)		$ 0.30	$ 0.29	[2]	$ 0.88	$ 0.87	[2]
Healthcare Trust of America Holdings, LP (HTALP)
Revenues:
Rental income		$ 103,875	$ 95,277		$ 301,570	$ 274,675
Interest and other operating income		67	257		203	1,834
Total revenues		103,942	95,534		301,773	276,509
Expenses:
Rental		32,921	28,526		92,855	85,179
General and administrative		6,430	5,935		19,229	18,137
Acquisition-related		907	2,802		3,365	8,647
Depreciation and amortization		40,518	35,802		115,179	104,346
Impairment		0	0		1,655	0
Total expenses		80,776	73,065		232,283	216,309
Income before other income (expense)		23,166	22,469		69,490	60,200
Interest expense:
Interest related to derivative financial instruments		(903)	(1,433)		(2,278)	(4,148)
(Loss) gain on change in fair value of derivative financial instruments, net		(2,383)	2,564		(3,079)	(857)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments		(3,286)	1,131		(5,357)	(5,005)
Interest related to debt		(13,536)	(14,119)		(41,499)	(37,802)
Gain on sales of real estate, net		152	11,766		152	11,766
(Loss) gain on extinguishment of debt, net		(14)	(5,028)		107	(4,663)
Other income		72	1		91	41
Net income		6,554	16,220		22,984	24,537
Net income attributable to noncontrolling interests		(20)	(28)		(77)	(106)
Net income attributable to common stockholders/unitholders		$ 6,534	$ 16,192		$ 22,907	$ 24,431
Earnings per common share/unit - basic:
Net income attributable to common stockholders/unitholders (usd per share)		$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Earnings per common share/unit - diluted:
Net income attributable to common stockholders/unitholders (usd per share)		$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Weighted average number of common shares/units outstanding:
Basic (in shares/units)		128,793	120,974	[2]	127,781	120,562	[2]
Diluted (in shares/units)		128,793	120,974	[2]	127,781	120,562	[2]
Dividends/Distributions declared per common share/unit (usd per share)		$ 0.30	$ 0.29	[2]	$ 0.88	$ 0.87	[2]
[1]	Includes amounts attributable to redeemable noncontrolling interests.
[2]	For the three and nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Operations (Parenthetical) (Unaudited)	Dec. 15, 2014
Reverse stock split conversion ratio	0.5
Healthcare Trust of America Holdings, LP (HTALP)
Reverse stock split conversion ratio	0.5

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Equity (Unaudited) - USD ($) $ in Thousands		Total	Class A Common Stock	Common StockClass A Common Stock		Additional Paid-In Capital		Cumulative Dividends in Excess of Earnings	Total Stockholders’ Equity	Noncontrolling Interests
Beginning balance, shares at Dec. 31, 2013	[1]			118,440,000
Beginning balance at Dec. 31, 2013		$ 1,399,749		$ 1,184	[1]	$ 2,128,082	[1]	$ (742,060)	$ 1,387,206	$ 12,543
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)	[1]			771,000
Issuance of common stock		17,742		$ 8	[1]	17,734	[1]		17,742
Share-based award transactions, net (in shares)	[1]			254,000
Share-based award transactions, net		3,279		$ 3	[1]	3,276	[1]		3,279
Repurchase and cancellation of common stock (in shares)	[1]			(29,000)
Repurchase and cancellation of common stock		(572)		$ (1)	[1]	(571)	[1]		(572)
Redemption of noncontrolling interest (in shares)	[1]			36,000
Redemption of noncontrolling interest		0				362	[1]		362	(362)
Dividends		(103,951)						(103,097)	(103,097)	(854)
Net income		24,415						24,179	24,179	236
Ending balance, shares at Sep. 30, 2014	[1]			119,472,000
Ending balance at Sep. 30, 2014		1,340,662		$ 1,194	[1]	2,148,883	[1]	(820,978)	1,329,099	11,563
Beginning balance, shares at Dec. 31, 2014			125,087,268	125,087,000
Beginning balance at Dec. 31, 2014		1,476,421		$ 1,251		2,281,932		(836,044)	1,447,139	29,282
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)				1,800,000
Issuance of common stock		43,649		$ 18		43,631			43,649
Share-based award transactions, net (in shares)				200,000
Share-based award transactions, net		4,462		$ 2		4,460			4,462
Repurchase and cancellation of common stock (in shares)				(49,000)
Repurchase and cancellation of common stock		(1,322)		$ (1)		(1,321)			(1,322)
Dividends		(111,766)						(110,071)	(110,071)	(1,695)
Net income		22,907						22,559	22,559	348
Ending balance, shares at Sep. 30, 2015			127,037,807	127,038,000
Ending balance at Sep. 30, 2015		$ 1,434,351		$ 1,270		$ 2,328,702		$ (923,556)	$ 1,406,416	$ 27,935
[1]	For the nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Equity (Parenthetical) (Unaudited)	Dec. 15, 2014
Statement of Stockholders' Equity [Abstract]
Reverse stock split conversion ratio	0.5

Condensed Consolidated Stateme8

Condensed Consolidated Statements of Changes In Partners' Capital (Unaudited) - USD ($) shares in Thousands, $ in Thousands		Total	Healthcare Trust of America Holdings, LP (HTALP)	Healthcare Trust of America Holdings, LP (HTALP)General Partner' Capital	Healthcare Trust of America Holdings, LP (HTALP)Limited Partners' Capital
Balance as of beginning of period (in units) at Dec. 31, 2013	[1]			118,440	1,527
Balance as of beginning of period at Dec. 31, 2013			$ 1,401,294	$ 1,387,476	$ 13,818
Increase (Decrease) in Partners' Capital [Roll Forward]
Issuance of general partner units (in units)	[1]			771
Issuance of general partner units			17,742	$ 17,742
Share-based award transactions, net (in units)	[1]			254	(3)
Share-based award transactions, net			3,279	$ 3,279
Redemptions of general partner units (in units)	[1]			(29)
Redemptions of general partner units			(572)	$ (572)
Redemption of limited partner units (in units)	[1]			36	(37)
Redemption of limited partner units			0	$ 362	$ (362)
Distributions			(104,019)	(103,097)	(922)
Net income		$ 24,179	24,431	$ 24,179	$ 252
Balance as of end of period (in units) at Sep. 30, 2014	[1]			119,472	1,487
Balance as of end of period at Sep. 30, 2014			1,342,155	$ 1,329,369	$ 12,786
Balance as of beginning of period (in units) at Dec. 31, 2014				125,087	2,155
Balance as of beginning of period at Dec. 31, 2014			1,476,421	$ 1,447,409	$ 29,012
Increase (Decrease) in Partners' Capital [Roll Forward]
Issuance of general partner units (in units)				1,800
Issuance of general partner units			43,649	$ 43,649
Share-based award transactions, net (in units)				200	(225)
Share-based award transactions, net			4,462	$ 4,462
Redemptions of general partner units (in units)				(49)
Redemptions of general partner units			(1,322)	$ (1,322)
Distributions			(111,766)	(110,071)	$ (1,695)
Net income		$ 22,559	22,907	$ 22,559	$ 348
Balance as of end of period (in units) at Sep. 30, 2015				127,038	1,930
Balance as of end of period at Sep. 30, 2015			$ 1,434,351	$ 1,406,686	$ 27,665
[1]	For the nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Condensed Consolidated Stateme9

Condensed Consolidated Statements of Changes In Partners' Capital (Parenthetical) (Unaudited)	Dec. 15, 2014
Reverse stock split conversion ratio	0.5
Healthcare Trust of America Holdings, LP (HTALP)
Reverse stock split conversion ratio	0.5

Condensed Consolidated Statem10

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 22,984	$ 24,537
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other	112,711	101,168
Share-based compensation expense	4,462	3,279
Bad debt expense	743	485
Gain on sales of real estate, net	(152)	(11,766)
Impairment	1,655	0
(Gain) loss on extinguishment of debt, net	(107)	4,663
Change in fair value of derivative financial instruments	3,079	857
Changes in operating assets and liabilities:
Receivables and other assets, net	(6,021)	(4,443)
Accounts payable and accrued liabilities	(4,124)	13,212
Security deposits, prepaid rent and other liabilities	3,429	(2,442)
Net cash provided by operating activities	138,659	129,550
Cash flows from investing activities:
Investments in real estate	(253,107)	(229,644)
Proceeds from sales of real estate	33,279	40,148
Capital expenditures	(17,330)	(24,167)
Collection of real estate notes receivable	0	20,000
Restricted cash, escrow deposits and other assets	2,994	(29,318)
Net cash used in investing activities	(234,164)	(222,981)
Cash flows from financing activities:
Proceeds from unsecured senior notes	0	297,615
Borrowings on unsecured revolving credit facility	387,000	213,000
Payments on unsecured revolving credit facility	(247,000)	(233,000)
Borrowings on unsecured term loans	100,000	0
Payments on secured real estate term loan and mortgage loans	(76,149)	(90,389)
Deferred financing costs	(289)	(6,093)
Security deposits	145	(1,245)
Proceeds from issuance of common stock, net	44,324	18,016
Repurchase and cancellation of common stock	(1,322)	(572)
Dividends	(108,891)	(102,506)
Distributions to noncontrolling interest of limited partners	(1,580)	(1,061)
Net cash provided by financing activities	96,238	93,765
Net change in cash and cash equivalents	733	334
Cash and cash equivalents - beginning of period	10,413	18,081
Cash and cash equivalents - end of period	11,146	18,415
Healthcare Trust of America Holdings, LP (HTALP)
Cash flows from operating activities:
Net income	22,984	24,537
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other	112,711	101,168
Share-based compensation expense	4,462	3,279
Bad debt expense	743	485
Gain on sales of real estate, net	(152)	(11,766)
Impairment	1,655	0
(Gain) loss on extinguishment of debt, net	(107)	4,663
Change in fair value of derivative financial instruments	3,079	857
Changes in operating assets and liabilities:
Receivables and other assets, net	(6,021)	(4,443)
Accounts payable and accrued liabilities	(4,124)	13,212
Security deposits, prepaid rent and other liabilities	3,429	(2,442)
Net cash provided by operating activities	138,659	129,550
Cash flows from investing activities:
Investments in real estate	(253,107)	(229,644)
Proceeds from sales of real estate	33,279	40,148
Capital expenditures	(17,330)	(24,167)
Collection of real estate notes receivable	0	20,000
Restricted cash, escrow deposits and other assets	2,994	(29,318)
Net cash used in investing activities	(234,164)	(222,981)
Cash flows from financing activities:
Proceeds from unsecured senior notes	0	297,615
Borrowings on unsecured revolving credit facility	387,000	213,000
Payments on unsecured revolving credit facility	(247,000)	(233,000)
Borrowings on unsecured term loans	100,000	0
Payments on secured real estate term loan and mortgage loans	(76,149)	(90,389)
Deferred financing costs	(289)	(6,093)
Security deposits	145	(1,245)
Proceeds from issuance of general partner units, net	44,324	18,016
Repurchase and cancellation of general partner units	(1,322)	(572)
Distributions to general partner	(108,891)	(102,506)
Distributions to limited partners and redeemable noncontrolling interests	(1,580)	(1,061)
Net cash provided by financing activities	96,238	93,765
Net change in cash and cash equivalents	733	334
Cash and cash equivalents - beginning of period	10,413	18,081
Cash and cash equivalents - end of period	$ 11,146	$ 18,415

Organization and Description of

Organization and Description of Business	9 Months Ended
	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business HTA, a Maryland corporation, and HTALP , a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006 . HTA operates as a REIT and is the general partner of HTALP , which is the operating partnership. As of September 30, 2015 , HTA owned a 98.5% partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including the LTIP units) in HTALP . As the sole general partner of HTALP , HTA has the full, exclusive and complete responsibility for HTALP ’s day-to-day management and control. HTA operates in an umbrella partnership REIT structure in which HTALP and its subsidiaries hold substantially all of the assets. HTA’s only material asset is its ownership of partnership interests of HTALP . As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP , issuing public equity from time to time and guaranteeing certain debts of HTALP . HTALP conducts the operations of the business and issues publicly-traded debt, but has no publicly-traded equity. HTA is one of the largest publicly-traded REITs focused on medical office buildings (“MOBs”) in the United States (“U.S.”) based on gross leasable area (“GLA”). We are primarily focused on acquiring, owning and operating high quality MOBs that are predominantly located on the campuses of, or aligned with, nationally or regionally recognized healthcare systems. In addition, we have strong industry relationships, a stable and diversified tenant mix and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we: (i) seek internal growth through proactive asset management, leasing and property management oversight; (ii) target mid-sized acquisitions of MOBs in markets with dominant healthcare systems, and with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT. We primarily invest in MOBs that are located on health system campuses, in community-core locations, or around university medical centers which we believe are core, critical real estate. We also focus on our key markets that have certain demographic and macro-economic trends and where we can utilize our institutional property management and leasing platform to generate strong tenant relationships and operating cost efficiencies. Our portfolio consists of MOBs and other facilities that serve the healthcare industry with an aggregate purchase price of $3.6 billion through September 30, 2015 . Effective December 15, 2014, HTA completed a reverse stock split (the “Reverse Stock Split”) of its common stock. As a result of the Reverse Stock Split, every two issued and outstanding shares of common stock were converted into one share of common stock. HTA’s par value and shares authorized remained unchanged. Concurrently with the Reverse Stock Split, HTALP effected a corresponding Reverse Stock Split of its outstanding units of limited partnership interests. The weighted average shares/units outstanding and per share/unit amounts for the three and nine months ended September 30, 2014 have been adjusted retroactively to reflect the Reverse Stock Split. Our principal executive office is located at 16435 North Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies The summary of significant accounting policies presented below is designed to assist in understanding our condensed consolidated financial statements. Such condensed consolidated financial statements and the accompanying notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to U.S. generally accepted accounting principles (“GAAP”) in all material respects and have been consistently applied in preparing our accompanying condensed consolidated financial statements. Basis of Presentation Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements. Interim Unaudited Financial Data Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2014 Annual Report on Form 10-K. Variable Interest Entities During 2014, we made loans totaling $80.5 million to five entities to acquire MOBs in order to facilitate potential Internal Revenue Code Section 1031 tax-deferred exchanges (the “Exchanges”). As of December 31, 2014 , our consolidated financial statements included the five VIEs as we were deemed to be the primary beneficiary. During the second quarter of 2015, we elected not to consummate the five outstanding Exchanges and, accordingly, the rights to the title and interests of the MOBs were transferred to us. Real Estate Investments Depreciation expense of buildings and improvements for the three months ended September 30, 2015 and 2014 , was $26.9 million and $22.6 million , respectively. Depreciation expense of buildings and improvements for the nine months ended September 30, 2015 and 2014 , was $74.9 million and $65.0 million , respectively. Recoverability of Real Estate Investments Real estate investments are evaluated for potential impairment whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. Impairment losses are recorded when indicators of impairment are present and the carrying amount of the asset is greater than the sum of future undiscounted cash flows expected to be generated by that asset over the remaining expected holding period. We would recognize an impairment loss when the carrying amount is not recoverable to the extent the carrying amount exceeds the fair value of the property. The fair value is generally based on discounted cash flow analyses. In performing the analysis we consider executed sales agreements or management’s best estimate of market comparables, future occupancy levels, rental rates, capitalization rates, lease-up periods and capital requirements. See Note 4 for further discussion. Recently Issued or Adopted Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. In July 2015, the FASB deferred the effective date of ASU 2014-09 to the first interim period within annual reporting periods beginning after December 15, 2017 along with the ability to early adopt as of the original effective date. We do not anticipate early adoption and we are evaluating the impact of adopting ASU 2014-09 on our consolidated financial statements. In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis. ASU 2015-02 affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. The amendments in ASU 2015-02 affect the following areas: (i) limited partnerships and similar legal entities; (ii) evaluating fees paid to a decision maker or a service provider as a variable interest; (iii) the effect of fee arrangements on the primary beneficiary determination; (iv) the effect of related parties on the primary beneficiary determination; and (v) certain investment funds. ASU 2015-02 is effective for fiscal years and for interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. We are evaluating this guidance, however, we do not believe ASU 2015-02 will have a significant impact on our consolidated financial statements, however, we believe ASU 2015-02 will likely increase our disclosure. In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 changes the presentation of debt issuance costs by requiring these costs related to a recognized debt liability to be presented in the consolidated balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by these amendments. In August 2015, the FASB issued ASU 2015-15 to include the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. ASU 2015-03 and 2015-15 are effective for the fiscal years beginning after December 15, 2015, and requires retrospective application. We do not believe the adoption of ASU 2015-03 and 2015-15 will have a significant impact on our consolidated financial statements. In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination has to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amount of the adjustment, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for fiscal years beginning after December 15, 2015 with early adoption permitted. We are evaluating this guidance, however, we do not believe the adoption of ASU 2015-16 will have a significant impact on our consolidated financial statements.

Investments in Real Estate

Investments in Real Estate	9 Months Ended
	Sep. 30, 2015
Investments [Abstract]
Investments in Real Estate	For the nine months ended September 30, 2015 , our investments had an aggregate purchase price of $254.6 million . We incurred $1.2 million of costs attributable to these investments, which were recorded in acquisition-related expenses in the accompanying condensed consolidated statements of operations. Since the investments were determined to be individually not significant, but significant on a collective basis, the allocations for the 2015 investments are set forth below in the aggregate (in thousands): September 30, 2015 Land $ 13,286 Building and improvements 229,386 Below market leasehold interests 2,698 Above market leases 1,254 In place leases 22,414 Below market leases (8,206 ) Above market leasehold interests (7,725 ) Net assets acquired 253,107 Other, net 1,503 Aggregate purchase price $ 254,610 The acquired intangible assets and liabilitie s referenced above had weighted average lives of 26.8 years and 52.4 years , respectively. The investments during the nine months ended September 30, 2014 were determined to be individually not significant, but significant on a collective basis. The allocations for these investments are set forth below in the aggregate (in thousands): September 30, 2014 Land $ 70,609 Building and improvements 227,458 Below market leasehold interests 98 Above market leases 1,708 In place leases 22,233 Below market leases (953 ) Above market debt, net (2,664 ) Net assets acquired 318,489 Other, net (939 ) Aggregate purchase price $ 317,550 The acquired intangible assets and liabilities referenced above had weighted average lives of 9.1 years and 8.5 years , respectively.

Dispositions

Dispositions	9 Months Ended
	Sep. 30, 2015
Disposal Group, Not Discontinued Operation, Disposal Disclosures [Abstract]
Dispositions	Dispositions During the three months ended September 30, 2015 , we completed dispositions of six MOBs for an aggregate gross sales price of $35.7 million , generating a gain of $0.2 million . These dispositions consisted of non-core buildings or buildings located outside of our key markets. During the second quarter of 2015, we recorded an impairment charge of $1.7 million on a MOB that we ultimately disposed of during the three months ended September 30, 2015 .

Intangible Assets and Liabiliti

Intangible Assets and Liabilities	9 Months Ended
	Sep. 30, 2015
Identified Intangibles, Net [Abstract]
Intangible Assets and Liabilities	Intangible Assets and Liabilities Intangible assets and liabilities consisted of the following as of September 30, 2015 and December 31, 2014 (in thousands, except weighted average remaining amortization): September 30, 2015 December 31, 2014 Balance Weighted Average Remaining Amortization in Years Balance Weighted Average Remaining Amortization in Years Assets: In place leases $ 248,648 11.0 $ 231,370 8.8 Tenant relationships 182,030 10.4 187,918 10.3 Above market leases 24,983 6.1 26,676 5.5 Below market leasehold interests 34,606 63.2 32,950 67.3 490,267 478,914 Accumulated amortization (209,404 ) (182,149 ) Total $ 280,863 16.5 $ 296,765 15.2 Liabilities: Below market leases $ 22,125 27.1 $ 14,188 11.5 Above market leasehold interests 11,582 53.9 3,857 32.1 33,707 18,045 Accumulated amortization (6,737 ) (5,620 ) Total $ 26,970 38.0 $ 12,425 17.1 In place leases and tenant relationships are included in lease intangibles in our condensed consolidated balance sheets. Above market leases and below market leasehold interests are included in other intangibles, net in our condensed consolidated balance sheets. Below market leases and above market leasehold interests are included in intangible liabilities, net in our condensed consolidated balance sheets. The following is a summary of the net intangible amortization for the three and nine months ended September 30, 2015 and 2014 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Amortization recorded against rental income related to above or below market leases $ 509 $ 505 $ 1,428 $ 1,534 Rental expense related to above or below market leasehold interests 94 112 327 358 Amortization expense related to in place leases and tenant relationships 12,266 12,066 36,371 36,247

Receivables and Other Assets

Receivables and Other Assets	9 Months Ended
	Sep. 30, 2015
Receivables and Other Assets [Abstract]
Receivables and Other Assets	Receivables and Other Assets Receivables and other assets consisted of the following as of September 30, 2015 and December 31, 2014 (in thousands): September 30, 2015 December 31, 2014 Tenant receivables, net $ 8,639 $ 11,896 Other receivables, net 7,090 5,539 Deferred financing costs, net 14,753 16,929 Deferred leasing costs, net 17,566 17,281 Straight-line rent receivables, net 63,427 56,433 Prepaid expenses, deposits, equipment and other, net 36,972 34,314 Derivative financial instruments - interest rate swaps — 1,714 Total $ 148,447 $ 144,106 The following is a summary of the amortization of deferred leasing costs and deferred financing costs for the three and nine months ended September 30, 2015 and 2014 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Amortization expense related to deferred leasing costs $ 1,013 $ 957 $ 2,941 $ 2,646 Interest expense related to deferred financing costs 774 724 2,457 2,319

Debt

Debt	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Debt	Debt Debt consisted of the following as of September 30, 2015 and December 31, 2014 (in thousands): September 30, 2015 December 31, 2014 Unsecured revolving credit facility $ 176,000 $ 36,000 Unsecured term loans 455,000 355,000 Unsecured senior notes 600,000 600,000 Fixed rate mortgages 316,611 392,399 Variable rate mortgages 29,113 29,474 1,576,724 1,412,873 Net discount (759 ) (412 ) Total $ 1,575,965 $ 1,412,461 Unsecured Credit Agreement Unsecured Revolving Credit Facility On February 11, 2015 , HTA and HTALP executed an amendment to the unsecured revolving credit and term loan facility (the “Unsecured Credit Agreement”) which added an additional lender and increased the amount available under the unsecured revolving credit facility from $800.0 million to $850.0 million . The other existing terms of the Unsecured Credit Agreement were unchanged. The actual amount of credit available to us is a function of certain loan-to-value and debt service coverage ratios set forth in the unsecured revolving credit facility. The maximum principal amount of the unsecured revolving credit facility may be increased, subject to additional financing being provided by our existing lenders or new lenders being added to the unsecured revolving credit facility. The unsecured revolving credit facility matures on January 31, 2020 . Borrowings under the unsecured revolving credit facility accrue interest equal to adjusted LIBOR , plus a margin ranging from 0.875% to 1.55% per annum based on our credit rating. We also pay a facility fee ranging from 0.125% to 0.30% per annum on the aggregate commitments under the unsecured revolving credit facility. As of September 30, 2015 , the margin associated with our borrowings was 1.05% per annum and the facility fee was 0.20% per annum. Unsecured Term Loan As of September 30, 2015 , we had a $300.0 million unsecured term loan outstanding that was guaranteed by HTA. During the nine months ended September 30, 2015 , we borrowed $100.0 million on the unsecured term loan. Borrowings accrue interest equal to adjusted LIBOR , plus a margin ranging from 0.90% to 1.80% per annum based on our credit rating. The margin associated with our borrowings as of September 30, 2015 was 1.15% per annum. Including the impact of the interest rate swaps associated with our unsecured term loan, the interest rate was 1.56% per annum, based on our current credit rating. The unsecured term loan matures on January 31, 2019 , and includes a one -year extension exercisable at the option of the borrower, subject to certain conditions. $155.0 Million Unsecured Term Loan As of September 30, 2015 , HTALP had a $155.0 million unsecured term loan outstanding that is guaranteed by HTA. The loan matures on July 19, 2019 , and the interest rate thereon is equal to LIBOR, plus a margin ranging from 1.55% to 2.40% per annum based on our credit rating. The margin associated with our borrowings as of September 30, 2015 was 1.70% per annum. We have interest rate swaps in place that fix the interest rate at 2.99% per annum, based on our current credit rating. The maximum principal amount under this unsecured term loan may be increased by us, subject to such additional financing being provided by our existing lender. $300.0 Million Unsecured Senior Notes due 2021 As of September 30, 2015 , HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and mature on July 15, 2021 . The unsecured senior notes are registered under the Securities Act of 1933, as amended (the “Securities Act”), bear interest at 3.38% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.21% of the principal amount thereof, with an effective yield to maturity of 3.50% per annum. $300.0 Million Unsecured Senior Notes due 2023 As of September 30, 2015 , HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and mature on April 15, 2023 . The unsecured senior notes are registered under the Securities Act, bear interest at 3.70% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.19% of the principal amount thereof, with an effective yield to maturity of 3.80% per annum. Fixed and Variable Rate Mortgages As of September 30, 2015 , HTALP and its subsidiaries had fixed and variable rate mortgages with interest rates ranging from 1.64% to 6.49% per annum and a weighted average interest rate of 5.33% per annum. Including the impact of the interest rate swap associated with our variable rate mortgage, the weighted average interest rate was 5.61% per annum. Future Debt Maturities The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of September 30, 2015 (in thousands): Year Amount 2015 $ 1,824 2016 69,657 2017 116,626 2018 14,429 2019 464,280 Thereafter 909,908 Total $ 1,576,724 The above scheduled debt maturities do not include the extension available to us under the Unsecured Credit Agreement as discussed above. We are required by the terms of our applicable debt agreements to meet various affirmative and negative covenants that we believe are customary for these types of facilities, such as limitations on the incurrence of debt by us and our subsidiaries that own unencumbered assets, limitations on the nature of HTALP ’s business, and limitations on distributions by HTALP and its subsidiaries that own unencumbered assets. Our debt agreements also impose various financial covenants on us, such as a maximum ratio of total indebtedness to total asset value, a minimum ratio of EBITDA to fixed charges, a minimum tangible net worth covenant, a maximum ratio of unsecured indebtedness to unencumbered asset value, rent coverage ratios and a minimum ratio of unencumbered net operating income to unsecured interest expense. As of September 30, 2015 , we believe that we were in compliance with all such financial covenants and reporting requirements. In addition, certain of our debt agreements include events of default provisions that we believe are customary for these types of facilities, including restricting HTA from making dividend distributions to its stockholders in the event HTA is in default thereunder, except to the extent necessary for HTA to maintain its REIT status.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The following table lists the derivative financial instrument assets and (liabilities) held by us as of September 30, 2015 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 100,000 LIBOR 0.86 % $ (353 ) Swap 6/15/2016 50,000 LIBOR 1.39 (622 ) Swap 7/17/2019 105,000 LIBOR 1.24 (689 ) Swap 7/17/2019 26,291 LIBOR + 1.45% 4.98 (2,590 ) Swap 5/1/2020 The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2014 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 100,000 LIBOR 0.86 % $ (443 ) Swap 6/15/2016 50,000 LIBOR 1.39 317 Swap 7/17/2019 105,000 LIBOR 1.24 1,397 Swap 7/17/2019 26,874 LIBOR + 1.45% 4.98 (2,445 ) Swap 5/1/2020 As of September 30, 2015 and December 31, 2014 , the gross fair value of our derivative financial instruments was as follows (in thousands): Asset Derivatives Liability Derivatives Fair Value Fair Value Derivatives Not Designated as Hedging Instruments: Balance Sheet Location September 30, 2015 December 31, 2014 Balance Sheet Location September 30, 2015 December 31, 2014 Interest rate swaps Receivables and other assets $ — $ 1,714 Derivative financial instruments $ 4,254 $ 2,888 There were no derivatives offset in our accompanying condensed consolidated balance sheets as of September 30, 2015 and December 31, 2014 . As of September 30, 2015 and December 31, 2014 , we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands): September 30, 2015 December 31, 2014 Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Asset derivatives $ — $ — $ — $ 1,714 $ — $ 1,714 Liability derivatives 4,254 — 4,254 2,888 — 2,888 We have agreements with each of our interest rate swap derivative counterparties that provide that if we default on certain of our unsecured indebtedness, then our counterparties could declare us in default on our interest rate swap derivative obligations resulting in an acceleration of the indebtedness. In addition, we are exposed to credit risk in the event of non-performance by our derivative counterparties. We believe we mitigate the credit risk by entering into agreements with credit-worthy counterparties. We record counterparty credit risk valuation adjustments on interest rate swap derivative assets in order to properly reflect the credit quality of the counterparty. In addition, our fair value of interest rate swap derivative liabilities is adjusted to reflect the impact of our credit quality. As of September 30, 2015 , there have been no termination events or events of default related to our interest rate swaps.

Stockholders' Equity and Partne

Stockholders' Equity and Partners' Capital	9 Months Ended
	Sep. 30, 2015
Equity [Abstract]
Stockholders' Equity and Partners' Capital	Stockholders’ Equity and Partners’ Capital HTALP ’s partnership agreement provides that it will distribute cash flows from operations and net sale proceeds to its partners in accordance with their overall ownership interests at such times and in such amounts as the general partner determines. Dividend distributions are made such that a holder of one partnership unit in HTALP will receive distributions from HTALP in an amount equal to the dividend distributions paid to the holder of one share of HTA’s common stock. In addition, for each share of common stock issued or redeemed by HTA, HTALP issues or redeems a corresponding number of partnership units. Common Stock Offerings In February 2014, HTA amended the at-the-market (“ATM”) offering program of its common stock with an aggregate sales price of up to $300.0 million , primarily to add sales agents to the program. During the nine months ended September 30, 2015 , HTA issued and sold 1,800,000 shares of common stock, at an average price of $25.00 per share and as of September 30, 2015 , $211.6 million remained available for issuance under the ATM. Common Stock Dividends See our accompanying condensed consolidated statements of operations for the dividends declared during three and nine months ended September 30, 2015 and 2014 . On October 27, 2015 , HTA declared a quarterly cash dividend of $0.295 to be paid on January 6, 2016 to stockholders of record for its common stock on December 31, 2015 . Incentive Plan HTA’s Amended and Restated 2006 Incentive Plan (the “Plan”) permits the grant of incentive awards to our employees, officers, non-employee directors and consultants as selected by our Board of Directors. The Plan authorizes the granting of awards in any of the following forms: options; stock appreciation rights; restricted stock; restricted or deferred stock units; performance awards; dividend equivalents; other stock-based awards, including units in HTALP ; and cash-based awards. Subject to adjustment as provided in the Plan, the aggregate number of awards reserved and available for issuance under the Plan is 5,000,000 . As of September 30, 2015 , there were 2,316,162 awards available for grant under the Plan. LTIP Units Awards under the LTIP consist of Series C units in HTALP , and were subject to the achievement of certain performance and market conditions in order to vest. Once vested, the Series C units were converted into common units of HTALP , which may be converted into shares o f HTA’s common stock. T he LTIP awards were fully expensed in 2013, except for 225,000 units with a grant date fair value of $20.00 per unit that would only vest in the eve nt of a change in control prior to May 16, 2015. These units were forfeited in May 2015. Restricted Common Stock For the three and nine months ended September 30, 2015 , we recognized compensation expense of $1.4 million and $4.5 million , respectively. For the three and nine months ended September 30, 2014 , we recognized compensation expense of $1.0 million and $3.3 million , respectively. Compensation expense for the three and nine months ended September 30, 2015 and 2014 were recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations. As of September 30, 2015 , there was $5.3 million of unrecognized compensation expense net of estimated forfeitures, which will be recognized over a remaining weighted average period of 1.4 years. The following is a summary of the activity in our restricted common stock during 2015 : Restricted Common Stock Weighted Average Grant Date Fair Value Balance as of December 31, 2014 463,050 $ 20.90 Granted 221,076 26.57 Vested (135,213 ) 21.89 Forfeited (21,378 ) 22.70 Balance as of September 30, 2015 527,535 $ 22.88

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Financial Instruments Reported at Fair Value - Recurring The table below presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ — $ — $ — Liabilities: Derivative financial instruments $ — $ 4,254 $ — $ 4,254 The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2014 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ 1,714 $ — $ 1,714 Liabilities: Derivative financial instruments $ — $ 2,888 $ — $ 2,888 There have been no transfers of assets or liabilities between levels. We will record any such transfers at the end of the reporting period in which a change of event occurs that results in a transfer. Although we have determined that the majority of the inputs used to value our interest rate swap derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. However, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our interest rate swap derivative positions and have determined that the credit valuation adjustments are not significant to their overall valuation. As a result, we have determined that our interest rate swap derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy. Financial Instruments Disclosed at Fair Value We consider the carrying values of cash and cash equivalents, tenant and other receivables, restricted cash and escrow deposits and accounts payable and accrued liabilities to approximate fair value for these financial instruments because of the short period of time between origination of the instruments and their expected realization. All of these financial instruments are considered Level 2. The fair value of debt is estimated using borrowing rates available to us with similar terms and maturities which is considered a Level 2 input. As of September 30, 2015 , the fair value of the debt was $1,608.2 million compared to the carrying value of $1,576.0 million . As of December 31, 2014 , the fair value of the debt was $1,447.4 million compared to the carrying value of $1,412.5 million .

Per Share Data of HTA

Per Share Data of HTA	9 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Per Share Data of HTA	Per Share Data of HTA HTA includes unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. For the three and nine months ended September 30, 2015 and 2014 , all of HTA’s earnings were distributed and the calculated earnings per share amount would be the same for all classes. The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the three and nine months ended September 30, 2015 and 2014 (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Numerator: Net income $ 6,554 $ 16,220 $ 22,984 $ 24,537 Net income attributable to noncontrolling interests (91 ) (188 ) (425 ) (358 ) Net income attributable to common stockholders $ 6,463 $ 16,032 $ 22,559 $ 24,179 Denominator: (1) Weighted average shares outstanding - basic 126,863 119,484 125,750 119,049 Dilutive shares 1,930 1,232 1,930 1,255 Weighted average shares outstanding - diluted 128,793 120,716 127,680 120,304 Earnings per common share - basic (1) Net income attributable to common stockholders $ 0.05 $ 0.13 $ 0.18 $ 0.20 Earnings per common share - diluted (1) Net income attributable to common stockholders $ 0.05 $ 0.13 $ 0.18 $ 0.20 (1) For the three and nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Per Unit Data of HTALP

Per Unit Data of HTALP	9 Months Ended
	Sep. 30, 2015
Healthcare Trust of America Holdings, LP (HTALP)
Earnings Per Share
Per Unit Data of HTALP	Per Unit Data of HTALP The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three and nine months ended September 30, 2015 and 2014 (in thousands, except per unit data): Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Numerator: Net income $ 6,554 $ 16,220 $ 22,984 $ 24,537 Net income attributable to noncontrolling interests (20 ) (28 ) (77 ) (106 ) Net income attributable to common unitholders $ 6,534 $ 16,192 $ 22,907 $ 24,431 Denominator: (1) Weighted average units outstanding - basic 128,793 120,974 127,781 120,562 Dilutive units — — — — Weighted average units outstanding - diluted 128,793 120,974 127,781 120,562 Earnings per common unit - basic: (1) Net income attributable to common unitholders $ 0.05 $ 0.13 $ 0.18 $ 0.20 Earnings per common unit - diluted: (1) Net income attributable to common unitholders $ 0.05 $ 0.13 $ 0.18 $ 0.20 (1) For the three and nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2015
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information The following is the supplemental cash flow information for the nine months ended September 30, 2015 and 2014 (in thousands): Nine Months Ended September 30, 2015 2014 Interest paid $ 39,570 $ 29,758 Income taxes paid 790 757 Supplemental Disclosure of Noncash Activities: Investing Activities: Accrued capital expenditures $ 1,833 $ 1,564 Debt and interest rate swaps assumed in acquisitions — 88,845 Financing Activities: Dividend distributions declared, but not paid $ 37,712 $ 34,652

Summary of Significant Accoun24

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.
Interim Unaudited Financial Data	Interim Unaudited Financial Data Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2014 Annual Report on Form 10-K.
Variable Interest Entities	Variable Interest Entities During 2014, we made loans totaling $80.5 million to five entities to acquire MOBs in order to facilitate potential Internal Revenue Code Section 1031 tax-deferred exchanges (the “Exchanges”). As of December 31, 2014 , our consolidated financial statements included the five VIEs as we were deemed to be the primary beneficiary. During the second quarter of 2015, we elected not to consummate the five outstanding Exchanges and, accordingly, the rights to the title and interests of the MOBs were transferred to us.
Real Estate Investments	Real Estate Investments Depreciation expense of buildings and improvements for the three months ended September 30, 2015 and 2014 , was $26.9 million and $22.6 million , respectively. Depreciation expense of buildings and improvements for the nine months ended September 30, 2015 and 2014 , was $74.9 million and $65.0 million , respectively.
Recoverability of Real Estate Investments	Recoverability of Real Estate Investments Real estate investments are evaluated for potential impairment whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. Impairment losses are recorded when indicators of impairment are present and the carrying amount of the asset is greater than the sum of future undiscounted cash flows expected to be generated by that asset over the remaining expected holding period. We would recognize an impairment loss when the carrying amount is not recoverable to the extent the carrying amount exceeds the fair value of the property. The fair value is generally based on discounted cash flow analyses. In performing the analysis we consider executed sales agreements or management’s best estimate of market comparables, future occupancy levels, rental rates, capitalization rates, lease-up periods and capital requirements. See Note 4 for further discussion.
Recently Issued or Adopted Accounting Pronouncements	Recently Issued or Adopted Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. In July 2015, the FASB deferred the effective date of ASU 2014-09 to the first interim period within annual reporting periods beginning after December 15, 2017 along with the ability to early adopt as of the original effective date. We do not anticipate early adoption and we are evaluating the impact of adopting ASU 2014-09 on our consolidated financial statements. In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis. ASU 2015-02 affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. The amendments in ASU 2015-02 affect the following areas: (i) limited partnerships and similar legal entities; (ii) evaluating fees paid to a decision maker or a service provider as a variable interest; (iii) the effect of fee arrangements on the primary beneficiary determination; (iv) the effect of related parties on the primary beneficiary determination; and (v) certain investment funds. ASU 2015-02 is effective for fiscal years and for interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. We are evaluating this guidance, however, we do not believe ASU 2015-02 will have a significant impact on our consolidated financial statements, however, we believe ASU 2015-02 will likely increase our disclosure. In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 changes the presentation of debt issuance costs by requiring these costs related to a recognized debt liability to be presented in the consolidated balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by these amendments. In August 2015, the FASB issued ASU 2015-15 to include the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. ASU 2015-03 and 2015-15 are effective for the fiscal years beginning after December 15, 2015, and requires retrospective application. We do not believe the adoption of ASU 2015-03 and 2015-15 will have a significant impact on our consolidated financial statements. In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination has to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amount of the adjustment, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for fiscal years beginning after December 15, 2015 with early adoption permitted. We are evaluating this guidance, however, we do not believe the adoption of ASU 2015-16 will have a significant impact on our consolidated financial statements.

Investments in Real Estate (Tab

Investments in Real Estate (Tables)	9 Months Ended
	Sep. 30, 2015
Investments [Abstract]
Schedule of Purchase Price Allocation	The allocations for these investments are set forth below in the aggregate (in thousands): September 30, 2014 Land $ 70,609 Building and improvements 227,458 Below market leasehold interests 98 Above market leases 1,708 In place leases 22,233 Below market leases (953 ) Above market debt, net (2,664 ) Net assets acquired 318,489 Other, net (939 ) Aggregate purchase price $ 317,550 Since the investments were determined to be individually not significant, but significant on a collective basis, the allocations for the 2015 investments are set forth below in the aggregate (in thousands): September 30, 2015 Land $ 13,286 Building and improvements 229,386 Below market leasehold interests 2,698 Above market leases 1,254 In place leases 22,414 Below market leases (8,206 ) Above market leasehold interests (7,725 ) Net assets acquired 253,107 Other, net 1,503 Aggregate purchase price $ 254,610

Intangible Assets and Liabili26

Intangible Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2015
Identified Intangibles, Net [Abstract]
Schedule of Intangible Assets and Liabilities	Intangible assets and liabilities consisted of the following as of September 30, 2015 and December 31, 2014 (in thousands, except weighted average remaining amortization): September 30, 2015 December 31, 2014 Balance Weighted Average Remaining Amortization in Years Balance Weighted Average Remaining Amortization in Years Assets: In place leases $ 248,648 11.0 $ 231,370 8.8 Tenant relationships 182,030 10.4 187,918 10.3 Above market leases 24,983 6.1 26,676 5.5 Below market leasehold interests 34,606 63.2 32,950 67.3 490,267 478,914 Accumulated amortization (209,404 ) (182,149 ) Total $ 280,863 16.5 $ 296,765 15.2 Liabilities: Below market leases $ 22,125 27.1 $ 14,188 11.5 Above market leasehold interests 11,582 53.9 3,857 32.1 33,707 18,045 Accumulated amortization (6,737 ) (5,620 ) Total $ 26,970 38.0 $ 12,425 17.1
Summary of Net Intangible Amortization	The following is a summary of the net intangible amortization for the three and nine months ended September 30, 2015 and 2014 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Amortization recorded against rental income related to above or below market leases $ 509 $ 505 $ 1,428 $ 1,534 Rental expense related to above or below market leasehold interests 94 112 327 358 Amortization expense related to in place leases and tenant relationships 12,266 12,066 36,371 36,247

Receivables and Other Assets (T

Receivables and Other Assets (Tables)	9 Months Ended
	Sep. 30, 2015
Receivables and Other Assets [Abstract]
Schedule of Receivables and Other Assets	Receivables and other assets consisted of the following as of September 30, 2015 and December 31, 2014 (in thousands): September 30, 2015 December 31, 2014 Tenant receivables, net $ 8,639 $ 11,896 Other receivables, net 7,090 5,539 Deferred financing costs, net 14,753 16,929 Deferred leasing costs, net 17,566 17,281 Straight-line rent receivables, net 63,427 56,433 Prepaid expenses, deposits, equipment and other, net 36,972 34,314 Derivative financial instruments - interest rate swaps — 1,714 Total $ 148,447 $ 144,106
Summary of Amortization of Deferred Leasing Costs and Deferred Financing Costs	The following is a summary of the amortization of deferred leasing costs and deferred financing costs for the three and nine months ended September 30, 2015 and 2014 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Amortization expense related to deferred leasing costs $ 1,013 $ 957 $ 2,941 $ 2,646 Interest expense related to deferred financing costs 774 724 2,457 2,319

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt	Debt consisted of the following as of September 30, 2015 and December 31, 2014 (in thousands): September 30, 2015 December 31, 2014 Unsecured revolving credit facility $ 176,000 $ 36,000 Unsecured term loans 455,000 355,000 Unsecured senior notes 600,000 600,000 Fixed rate mortgages 316,611 392,399 Variable rate mortgages 29,113 29,474 1,576,724 1,412,873 Net discount (759 ) (412 ) Total $ 1,575,965 $ 1,412,461
Summary of Debt Maturities and Scheduled Principal Debt Repayments	The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of September 30, 2015 (in thousands): Year Amount 2015 $ 1,824 2016 69,657 2017 116,626 2018 14,429 2019 464,280 Thereafter 909,908 Total $ 1,576,724

Derivative Financial Instrume29

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instrument Assets and (Liabilities) Held	The following table lists the derivative financial instrument assets and (liabilities) held by us as of September 30, 2015 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 100,000 LIBOR 0.86 % $ (353 ) Swap 6/15/2016 50,000 LIBOR 1.39 (622 ) Swap 7/17/2019 105,000 LIBOR 1.24 (689 ) Swap 7/17/2019 26,291 LIBOR + 1.45% 4.98 (2,590 ) Swap 5/1/2020 The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2014 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 100,000 LIBOR 0.86 % $ (443 ) Swap 6/15/2016 50,000 LIBOR 1.39 317 Swap 7/17/2019 105,000 LIBOR 1.24 1,397 Swap 7/17/2019 26,874 LIBOR + 1.45% 4.98 (2,445 ) Swap 5/1/2020
Gross Fair Value of Derivative Financial Instruments	As of September 30, 2015 and December 31, 2014 , the gross fair value of our derivative financial instruments was as follows (in thousands): Asset Derivatives Liability Derivatives Fair Value Fair Value Derivatives Not Designated as Hedging Instruments: Balance Sheet Location September 30, 2015 December 31, 2014 Balance Sheet Location September 30, 2015 December 31, 2014 Interest rate swaps Receivables and other assets $ — $ 1,714 Derivative financial instruments $ 4,254 $ 2,888
Schedule of Derivatives Subject to Master Netting Arrangements	As of September 30, 2015 and December 31, 2014 , we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands): September 30, 2015 December 31, 2014 Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Asset derivatives $ — $ — $ — $ 1,714 $ — $ 1,714 Liability derivatives 4,254 — 4,254 2,888 — 2,888

Stockholders' Equity and Part30

Stockholders' Equity and Partners' Capital (Tables)	9 Months Ended
	Sep. 30, 2015
Equity [Abstract]
Schedule of Restricted Common Stock Activity	The following is a summary of the activity in our restricted common stock during 2015 : Restricted Common Stock Weighted Average Grant Date Fair Value Balance as of December 31, 2014 463,050 $ 20.90 Granted 221,076 26.57 Vested (135,213 ) 21.89 Forfeited (21,378 ) 22.70 Balance as of September 30, 2015 527,535 $ 22.88

Fair Value of Financial Instr31

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2015
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The table below presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ — $ — $ — Liabilities: Derivative financial instruments $ — $ 4,254 $ — $ 4,254 The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2014 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ 1,714 $ — $ 1,714 Liabilities: Derivative financial instruments $ — $ 2,888 $ — $ 2,888

Per Share Data of HTA (Tables)

Per Share Data of HTA (Tables)	9 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the three and nine months ended September 30, 2015 and 2014 (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Numerator: Net income $ 6,554 $ 16,220 $ 22,984 $ 24,537 Net income attributable to noncontrolling interests (91 ) (188 ) (425 ) (358 ) Net income attributable to common stockholders $ 6,463 $ 16,032 $ 22,559 $ 24,179 Denominator: (1) Weighted average shares outstanding - basic 126,863 119,484 125,750 119,049 Dilutive shares 1,930 1,232 1,930 1,255 Weighted average shares outstanding - diluted 128,793 120,716 127,680 120,304 Earnings per common share - basic (1) Net income attributable to common stockholders $ 0.05 $ 0.13 $ 0.18 $ 0.20 Earnings per common share - diluted (1) Net income attributable to common stockholders $ 0.05 $ 0.13 $ 0.18 $ 0.20 (1) For the three and nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Per Unit Data of HTALP (Tables)

Per Unit Data of HTALP (Tables)	9 Months Ended
	Sep. 30, 2015
Healthcare Trust of America Holdings, LP (HTALP)
Earnings Per Share
Schedule of Earnings Per Unit, Basic and Diluted	The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three and nine months ended September 30, 2015 and 2014 (in thousands, except per unit data): Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Numerator: Net income $ 6,554 $ 16,220 $ 22,984 $ 24,537 Net income attributable to noncontrolling interests (20 ) (28 ) (77 ) (106 ) Net income attributable to common unitholders $ 6,534 $ 16,192 $ 22,907 $ 24,431 Denominator: (1) Weighted average units outstanding - basic 128,793 120,974 127,781 120,562 Dilutive units — — — — Weighted average units outstanding - diluted 128,793 120,974 127,781 120,562 Earnings per common unit - basic: (1) Net income attributable to common unitholders $ 0.05 $ 0.13 $ 0.18 $ 0.20 Earnings per common unit - diluted: (1) Net income attributable to common unitholders $ 0.05 $ 0.13 $ 0.18 $ 0.20 (1) For the three and nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Supplemental Cash Flow Inform34

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2015
Supplemental Cash Flow Elements [Abstract]
Schedule of Supplemental Cash Flow Information	The following is the supplemental cash flow information for the nine months ended September 30, 2015 and 2014 (in thousands): Nine Months Ended September 30, 2015 2014 Interest paid $ 39,570 $ 29,758 Income taxes paid 790 757 Supplemental Disclosure of Noncash Activities: Investing Activities: Accrued capital expenditures $ 1,833 $ 1,564 Debt and interest rate swaps assumed in acquisitions — 88,845 Financing Activities: Dividend distributions declared, but not paid $ 37,712 $ 34,652

Organization and Description 35

Organization and Description of Business (Details) $ in Billions	Dec. 15, 2014	Sep. 30, 2015USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General partnership interest percentage		98.50%
Purchased property inception to current date		$ 3.6
Reverse stock split conversion ratio	0.5

Summary of Significant Accoun36

Summary of Significant Accounting Policies (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Dec. 31, 2014USD ($)entity
Accounting Policies [Line Items]
VIEs, total loans					$ 80.5
Number of VIEs | entity					5
Building and Improvements
Accounting Policies [Line Items]
Depreciation expense	$ 26.9	$ 22.6	$ 74.9	$ 65

Investments in Real Estate (Det

Investments in Real Estate (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Investments [Abstract]
Closing costs	$ 1,200
Business Acquisition, Purchase Price Allocation, Real Estate [Abstract]
Land	13,286	$ 70,609
Building and improvements	229,386	227,458
Below market leasehold interests	2,698	98
Above market leases	1,254	1,708
In place leases	22,414	22,233
Below market leases	(8,206)	(953)
Above market leasehold interests	(7,725)
Above market debt, net		(2,664)
Net assets acquired	253,107	318,489
Other, net	1,503	(939)
Aggregate purchase price	$ 254,610	$ 317,550
Weighted average lives of acquired intangible assets	26 years 9 months 21 days	9 years 1 month 6 days
Weighted average lives of acquired intangible liabilities	52 years 5 months 8 days	8 years 6 months

Dispositions (Details)

Dispositions (Details) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2015USD ($)building	Jun. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)
Disposal Group, Not Discontinued Operation, Disposal Disclosures [Abstract]
Number of MOBs disposed | building	6
Aggregate gross sales price of disposed medical office buildings	$ 35,700
Gain from sale of disposed medical office buildings	152		$ 11,766	$ 152	$ 11,766
Impairment charge on medical office building marketed for sale	$ 0	$ 1,655	$ 0	$ 1,655	$ 0

Intangible Assets and Liabili39

Intangible Assets and Liabilities - Summary of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Assets:
Gross	$ 490,267	$ 478,914
Accumulated amortization	(209,404)	(182,149)
Total	$ 280,863	$ 296,765
Weighted Average Remaining Amortization in Years	16 years 6 months	15 years 2 months 12 days
Liabilities:
Gross	$ 33,707	$ 18,045
Accumulated amortization	(6,737)	(5,620)
Total	$ 26,970	$ 12,425
Weighted Average Remaining Amortization in Years	37 years 11 months 26 days	17 years 1 month 6 days
Below Market Leases
Liabilities:
Gross	$ 22,125	$ 14,188
Weighted Average Remaining Amortization in Years	27 years 1 month 13 days	11 years 6 months
Above Market Leasehold Interests
Liabilities:
Gross	$ 11,582	$ 3,857
Weighted Average Remaining Amortization in Years	53 years 11 months 8 days	32 years 1 month 6 days
In Place Leases
Assets:
Gross	$ 248,648	$ 231,370
Weighted Average Remaining Amortization in Years	11 years 14 days	8 years 9 months 18 days
Tenant Relationships
Assets:
Gross	$ 182,030	$ 187,918
Weighted Average Remaining Amortization in Years	10 years 4 months 20 days	10 years 3 months 18 days
Above Market Leases
Assets:
Gross	$ 24,983	$ 26,676
Weighted Average Remaining Amortization in Years	6 years 25 days	5 years 6 months
Below Market Leasehold Interests
Assets:
Gross	$ 34,606	$ 32,950
Weighted Average Remaining Amortization in Years	63 years 2 months 1 day	67 years 3 months 18 days

Intangible Assets and Liabili40

Intangible Assets and Liabilities - Summary of Intangible Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Amortization recorded against rental income related to above or below market leases
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]
Amortization of intangible assets and liabilities	$ 509	$ 505	$ 1,428	$ 1,534
Rental expense related to above or below market leasehold interests
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]
Amortization of intangible assets and liabilities	94	112	327	358
Amortization expense related to in place leases and tenant relationships
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]
Amortization of intangible assets and liabilities	$ 12,266	$ 12,066	$ 36,371	$ 36,247

Receivables and Other Assets -

Receivables and Other Assets - Schedule of Receivables and Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Receivables and Other Assets [Abstract]
Tenant receivables, net	$ 8,639	$ 11,896
Other receivables, net	7,090	5,539
Deferred financing costs, net	14,753	16,929
Deferred leasing costs, net	17,566	17,281
Straight-line rent receivables, net	63,427	56,433
Prepaid expenses, deposits, equipment and other, net	36,972	34,314
Derivative financial instruments - interest rate swaps	0	1,714
Total	$ 148,447	$ 144,106

Receivables and Other Assets 42

Receivables and Other Assets - Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Receivables and Other Assets [Abstract]
Amortization expense related to deferred leasing costs	$ 1,013	$ 957	$ 2,941	$ 2,646
Interest expense related to deferred financing costs	$ 774	$ 724	$ 2,457	$ 2,319

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Debt Instrument
Total debt, gross	$ 1,576,724	$ 1,412,873
Net discount	(759)	(412)
Total	1,575,965	1,412,461
Unsecured Term Loans
Debt Instrument
Total debt, gross	455,000	355,000
Unsecured Senior Notes
Debt Instrument
Total debt, gross	600,000	600,000
Mortgages | Fixed Rate Mortgages
Debt Instrument
Total debt, gross	316,611	392,399
Mortgages | Variable Rate Mortgages
Debt Instrument
Total debt, gross	29,113	29,474
Unsecured Revolving Credit Facility
Debt Instrument
Line of credit facility, amount outstanding	$ 176,000	$ 36,000

Debt - Textuals (Details)

Debt - Textuals (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Feb. 11, 2015	Dec. 31, 2014	Nov. 19, 2014
Debt Instrument
Outstanding amount	$ 1,576,724,000		$ 1,412,873,000
Unsecured Term Loans
Debt Instrument
Outstanding amount	$ 455,000,000		355,000,000
Unsecured Term Loans | $300.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate	1.15%
Outstanding amount	$ 300,000,000
Additional borrowings	$ 100,000,000
Weighted average interest rate with interest rate swap impact	1.56%
Unsecured credit agreement, extension option period	1 year
Unsecured Term Loans | $300.0 Million Unsecured Term Loan | Minimum
Debt Instrument
Basis spread on variable rate	0.90%
Unsecured Term Loans | $300.0 Million Unsecured Term Loan | Maximum
Debt Instrument
Basis spread on variable rate	1.80%
Unsecured Term Loans | $155.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate	1.70%
Weighted average interest rate with interest rate swap impact	2.99%
Debt instrument, face amount	$ 155,000,000
Unsecured Term Loans | $155.0 Million Unsecured Term Loan | Minimum
Debt Instrument
Basis spread on variable rate	1.55%
Unsecured Term Loans | $155.0 Million Unsecured Term Loan | Maximum
Debt Instrument
Basis spread on variable rate	2.40%
Unsecured Senior Notes
Debt Instrument
Outstanding amount	$ 600,000,000		$ 600,000,000
Unsecured Senior Notes | $300.0 Million Unsecured Senior Notes Due 2021
Debt Instrument
Debt instrument, face amount	$ 300,000,000
Debt instrument, stated interest rate	3.38%
Debt instrument, percentage of principal amount received	99.21%
Debt instrument, effective interest rate	3.50%
Unsecured Senior Notes | $300.0 Million Unsecured Senior Notes Due 2023
Debt Instrument
Debt instrument, face amount	$ 300,000,000
Debt instrument, stated interest rate	3.70%
Debt instrument, percentage of principal amount received	99.19%
Debt instrument, effective interest rate	3.80%
Mortgages
Debt Instrument
Weighted average interest rate with interest rate swap impact	5.61%
Effective percentage rate range, minimum	1.64%
Effective percentage rate range, maximum	6.49%
Weighted average interest rate	5.33%
Unsecured Revolving Credit Facility
Debt Instrument
Line of credit facility, borrowing capacity		$ 850,000,000		$ 800,000,000
Basis spread on variable rate	1.05%
Line of credit facility, commitment fee percentage	0.20%
Unsecured Revolving Credit Facility | Minimum
Debt Instrument
Basis spread on variable rate	0.875%
Line of credit facility, commitment fee percentage	0.125%
Unsecured Revolving Credit Facility | Maximum
Debt Instrument
Basis spread on variable rate	1.55%
Line of credit facility, commitment fee percentage	0.30%

Debt - Principal Maturity Sched

Debt - Principal Maturity Schedule (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Debt Disclosure [Abstract]
2,015	$ 1,824
2,016	69,657
2,017	116,626
2,018	14,429
2,019	464,280
Thereafter	909,908
Total	$ 1,576,724	$ 1,412,873

Derivative Financial Instrume46

Derivative Financial Instruments - Table of Derivative Financial Instruments (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Derivative
Fair value, liability	$ (4,254)	$ (2,888)
Fair value, asset	0	1,714
Interest Rate Swap | 0.86%
Derivative
Notional Amount	$ 100,000	$ 100,000
Index	LIBOR	LIBOR
Rate	0.86%	0.86%
Fair value, liability	$ (353)	$ (443)
Interest Rate Swap | 1.39%
Derivative
Notional Amount	$ 50,000	$ 50,000
Index	LIBOR	LIBOR
Rate	1.39%	1.39%
Fair value, liability	$ (622)
Fair value, asset		$ 317
Interest Rate Swap | 1.24%
Derivative
Notional Amount	$ 105,000	$ 105,000
Index	LIBOR	LIBOR
Rate	1.24%	1.24%
Fair value, liability	$ (689)
Fair value, asset		$ 1,397
Interest Rate Swap | 4.98%
Derivative
Notional Amount	$ 26,291	$ 26,874
Index	LIBOR + 1.45%	LIBOR + 1.45%
Rate	4.98%	4.98%
Fair value, liability	$ (2,590)	$ (2,445)
Basis spread on variable rate	1.45%	1.45%

Derivative Financial Instrume47

Derivative Financial Instruments - Derivative Instruments Fair Value Table (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Derivatives, Fair Value
Derivative financial instruments, asset	$ 0	$ 1,714
Derivative financial instruments, liability	4,254	2,888
Interest Rate Swap | Not Designated as Hedging Instrument | Receivables and Other Assets
Derivatives, Fair Value
Derivative financial instruments, asset	0	1,714
Interest Rate Swap | Not Designated as Hedging Instrument | Derivative Financial Instruments
Derivatives, Fair Value
Derivative financial instruments, liability	$ 4,254	$ 2,888

Derivative Financial Instrume48

Derivative Financial Instruments - Derivative Offsetting (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative financial instruments, asset	$ 0	$ 1,714
Derivative assets, amounts subject to enforceable master netting arrangements	0	0
Derivative assets, net amounts	0	1,714
Derivative liabilities	4,254	2,888
Derivative liabilities, amounts subject to enforceable master netting arrangements	0	0
Derivative liabilities, net amounts	$ 4,254	$ 2,888

Stockholders' Equity and Part49

Stockholders' Equity and Partners' Capital - Textuals (Details)	Oct. 27, 2015$ / shares	May. 31, 2015$ / sharesshares	Feb. 28, 2014USD ($)	Sep. 30, 2015USD ($)$ / sharesshares	Sep. 30, 2014USD ($)$ / shares		Sep. 30, 2015USD ($)$ / sharesshares	Sep. 30, 2014USD ($)$ / shares
Common Stock Dividends
Dividends declared (in usd per share)				$ 0.30	$ 0.29	[1]	$ 0.88	$ 0.87	[1]
LTIP Units
Incentive Plan
Number of forfeited units/shares | shares		225,000
Weighted average grant date fair value of units forfeited (in usd per share)		$ 20
Restricted Common Stock
Incentive Plan
Number of forfeited units/shares | shares							21,378
Weighted average grant date fair value of units forfeited (in usd per share)							$ 22.70
Allocated share-based compensation expense | $				$ 1,400,000	$ 1,000,000		$ 4,500,000	$ 3,300,000
Nonvested awards, total compensation cost not yet recognized | $				$ 5,300,000			$ 5,300,000
Period for recognition							1 year 4 months 24 days
2006 Incentive Plan
Incentive Plan
Number of shares authorized | shares				5,000,000			5,000,000
Number of shares available for grant | shares				2,316,162			2,316,162
Subsequent Event
Common Stock Dividends
Dividends declared (in usd per share)	$ 0.295
At the Market
Common Stock Offerings
Number of shares issued and sold | shares							1,800,000
Sale of stock, average price per share (in usd per share)							$ 25
Remaining available amount of common stock for issuance | $							$ 211,600,000
At the Market | Maximum
Common Stock Offerings
Maximum amount of common stock authorized | $			$ 300,000,000
Healthcare Trust of America Holdings, LP (HTALP)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend distribution ratio							1
Common Stock Dividends
Dividends declared (in usd per share)				$ 0.30	$ 0.29	[1]	$ 0.88	$ 0.87	[1]
[1]	For the three and nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Stockholders' Equity and Part50

Stockholders' Equity and Partners' Capital - Restricted Common Stock Activity (Details) - Restricted Common Stock	9 Months Ended
	Sep. 30, 2015$ / sharesshares
Restricted Common Stock
Balance as of beginning of period (in shares)	463,050
Granted (in shares)	221,076
Vested (in shares)	(135,213)
Forfeited (in shares)	(21,378)
Balance as of end of period (in shares)	527,535
Weighted Average Grant Date Fair Value
Balance as of beginning of period (in usd per share) | $ / shares	$ 20.90
Granted (in usd per share) | $ / shares	26.57
Vested (in usd per share) | $ / shares	21.89
Forfeited (in usd per share) | $ / shares	22.70
Balance as of end of period (in usd per share) | $ / shares	$ 22.88

Fair Value of Financial Instr51

Fair Value of Financial Instruments - Assets and Liabilities at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Assets:
Derivative financial instruments, asset	$ 0	$ 1,714
Liabilities:
Derivative financial instruments, liability	4,254	2,888
Fair Value, Measurements, Recurring
Assets:
Derivative financial instruments, asset	0	1,714
Liabilities:
Derivative financial instruments, liability	4,254	2,888
Fair Value, Measurements, Recurring | Level 1
Assets:
Derivative financial instruments, asset	0	0
Liabilities:
Derivative financial instruments, liability	0	0
Fair Value, Measurements, Recurring | Level 2
Assets:
Derivative financial instruments, asset	0	1,714
Liabilities:
Derivative financial instruments, liability	4,254	2,888
Fair Value, Measurements, Recurring | Level 3
Assets:
Derivative financial instruments, asset	0	0
Liabilities:
Derivative financial instruments, liability	$ 0	$ 0

Fair Value of Financial Instr52

Fair Value of Financial Instruments - Textuals (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Debt, fair value	$ 1,608,200	$ 1,447,400
Debt, carrying value	$ 1,575,965	$ 1,412,461

Per Share Data of HTA (Details)

Per Share Data of HTA (Details) $ / shares in Units, shares in Thousands, $ in Thousands		Dec. 15, 2014	Sep. 30, 2015USD ($)$ / sharesshares	Sep. 30, 2014USD ($)$ / sharesshares		Sep. 30, 2015USD ($)$ / sharesshares	Sep. 30, 2014USD ($)$ / sharesshares
Numerator:
Net income | $			$ 6,554	$ 16,220		$ 22,984	$ 24,537
Net income attributable to noncontrolling interests | $	[1]		(91)	(188)		(425)	(358)
Net income attributable to common stockholders/unitholders | $			$ 6,463	$ 16,032		$ 22,559	$ 24,179
Denominator:
Weighted average shares outstanding - basic			126,863	119,484	[2]	125,750	119,049	[2]
Dilutive shares	[2]		1,930	1,232		1,930	1,255
Weighted average number of shares/units outstanding — diluted			128,793	120,716	[2]	127,680	120,304	[2]
Earnings per common share - basic
Net income attributable to common stockholders (usd per share) | $ / shares			$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Earnings per common share - diluted
Net income attributable to common stockholders (usd per share) | $ / shares			$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Reverse stock split conversion ratio		0.5
[1]	Includes amounts attributable to redeemable noncontrolling interests.
[2]	For the three and nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Per Unit Data of HTALP (Details

Per Unit Data of HTALP (Details) $ / shares in Units, shares in Thousands, $ in Thousands		Dec. 15, 2014	Sep. 30, 2015USD ($)$ / sharesshares	Sep. 30, 2014USD ($)$ / sharesshares		Sep. 30, 2015USD ($)$ / sharesshares	Sep. 30, 2014USD ($)$ / sharesshares
Numerator:
Net income | $			$ 6,554	$ 16,220		$ 22,984	$ 24,537
Net income attributable to noncontrolling interests | $	[1]		(91)	(188)		(425)	(358)
Net income attributable to common stockholders/unitholders | $			$ 6,463	$ 16,032		$ 22,559	$ 24,179
Denominator:
Weighted average units outstanding - basic			126,863	119,484	[2]	125,750	119,049	[2]
Dilutive units	[2]		1,930	1,232		1,930	1,255
Weighted average number of shares/units outstanding — diluted			128,793	120,716	[2]	127,680	120,304	[2]
Earnings per common unit - basic:
Net income attributable to common unitholders (usd per share) | $ / shares			$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Earnings per common unit - diluted:
Net income attributable to common unitholders (usd per share) | $ / shares			$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Reverse stock split conversion ratio		0.5
Healthcare Trust of America Holdings, LP (HTALP)
Numerator:
Net income | $			$ 6,554	$ 16,220		$ 22,984	$ 24,537
Net income attributable to noncontrolling interests | $			(20)	(28)		(77)	(106)
Net income attributable to common stockholders/unitholders | $			$ 6,534	$ 16,192		$ 22,907	$ 24,431
Denominator:
Weighted average units outstanding - basic			128,793	120,974	[2]	127,781	120,562	[2]
Dilutive units	[2]		0	0		0	0
Weighted average number of shares/units outstanding — diluted			128,793	120,974	[2]	127,781	120,562	[2]
Earnings per common unit - basic:
Net income attributable to common unitholders (usd per share) | $ / shares			$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Earnings per common unit - diluted:
Net income attributable to common unitholders (usd per share) | $ / shares			$ 0.05	$ 0.13	[2]	$ 0.18	$ 0.20	[2]
Reverse stock split conversion ratio		0.5
[1]	Includes amounts attributable to redeemable noncontrolling interests.
[2]	For the three and nine months ended September 30, 2014, amounts have been adjusted retroactively to reflect a 1-for-2 reverse stock split effected on December 15, 2014.

Supplemental Cash Flow Inform55

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Supplemental Disclosure of Cash Flow Information:
Interest paid	$ 39,570	$ 29,758
Income taxes paid	790	757
Investing Activities:
Accrued capital expenditures	1,833	1,564
Debt and interest rate swaps assumed in acquisitions	0	88,845
Financing Activities:
Dividend distributions declared, but not paid	$ 37,712	$ 34,652